BMCS Lectureship: Inaugural Lecture


1 May 2014, Burlington House, London

The most recent in the successful series of ‘Thursday evening’ public lectures in Burlington House saw Dr Mike Waring, who is a Principal Scientist and Associate Science Director in Medicinal Chemistry at AstraZeneca in Alderley Park, give a talk entitled ‘Molecular Oncology – Past, Present and Future of Anti-Cancer Drug Design’.  

Following this presentation Mike will give a series of up to six lectures throughout the UK in 2014-2015 as the winner of the 2013 RSC Biological and Medicinal Chemistry Lectureship Award. 

The award was initiated to stimulate interest and awareness among the general public of the role of medicinal chemistry in the discovery of life-saving new medicines and to inspire the next generation of young chemists.  The list of nominees was extremely strong and Mike was a worthy winner.  

In his talk he described the discovery of effective anti-cancer drugs, which represents one of the greatest challenges to face humanity.  

Whilst great progress has been made in both our understanding and our ability to discover new treatments, significant challenges remain. 

The lecture showcased how some of today’s recognised drugs were discovered and how modern medicinal chemistry approaches have been applied to discover new treatments, which show great promise for the future. Mike’s talk was very well received and stimulated lively discussion.

photo of Dr Mike Waring

Dr Mike Waring, AstraZeneca

photo of Dr Mike Waring's lecture

Details of the remaining lectures by Mike Waring in this series can be found on the BMCS forthcoming events link at the top of the page. 


Molecular Oncology - Past, Present and Future of Anti-Cancer Drug Design

Thursday 1 May 2014

Biological & Medicinal Chemistry Sector (BMCS)

BMCS aims to further the interests of all members of the RSC, both industrial and academic, involved in the pursuit and understanding of biologically active molecules